Item(by='MrAlex94', descendants=None, kids=None, score=None, time=1608389323, title=None, item_type='comment', url=None, parent=25475256, text='&gt; Later, a vaccine candidate that has been proven safe in clinical trials could be given to a group of healthy adults in this age range, who are then exposed to the virus in a controlled environment. They would then be closely monitored by medics and researchers to see if the vaccine is successful in preventing infection, as well as identifying any side effects.<p>&gt; <a href="https:&#x2F;&#x2F;www.thelancet.com&#x2F;journals&#x2F;lanres&#x2F;article&#x2F;PIIS2213-2600(20)30518-X&#x2F;fulltext" rel="nofollow">https:&#x2F;&#x2F;www.thelancet.com&#x2F;journals&#x2F;lanres&#x2F;article&#x2F;PIIS2213-2...</a><p>I imagine they will do what they did for the vaccine candidate ChAdOx1 nCoV-2019 and swab at least every week to test for infection.<p>Do you have any source to back up your claim that a challenge trial wouldnâ€™t work for SARS-CoV-2?')